Menkes disease mutations and response to early copper histidine treatment

@article{Kaler1996MenkesDM,
  title={Menkes disease mutations and response to early copper histidine treatment},
  author={S. Kaler},
  journal={Nature Genetics},
  year={1996},
  volume={13},
  pages={21-22}
}
  • S. Kaler
  • Published 1996
  • Biology, Medicine
  • Nature Genetics
    • View on Springer
    ncbi.nlm.nih.gov
    57 Citations
    Background Citations
    15
    Methods Citations
    1
    Results Citations
    2

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

        57 Citations
        Citation Type

        Citation Type

        Copper‐replacement treatment for symptomatic Menkes disease: ethical considerations
        • 46
        The molecular mechanisms of copper metabolism and its roles in human diseases
        • 2
        Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time.
        • 11
        Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model
        • 8
        13 novel putative mutations in ATP7A found in a cohort of 25 Italian families
        • 2
        Modulating copper metabolism as a strategy to treat neurodegenerative tauopathies
        Copper comes of age in Melbourne.
        • 2
        Menkes disease: what a multidisciplinary approach can do
        • 14
        • PDF
        Adsorption of copper (II) using modified activated carbon prepared from Pomegranate wood: Optimization by bee algorithm and response surface methodology
        • 83
        Copper mediated neurological disorder: visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease.
        • 51
        • PDF

        References

        SHOWING 1-7 OF 7 REFERENCES
        Early copper-histidine treatment for Menkes disease
        • 80
        Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion.
        • 62
        Early copper therapy in classic Menkes disease patients with a novel splicing mutation
        • 78
        Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
        • 103
        Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions.
        • 324
        Requirements for intercistronic distance and level of eukaryotic initiation factor 2 activity in reinitiation on GCN4 mRNA vary with the downstream cistron.
        • 94
        • PDF
        An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
        • M. Kozak
        • Biology, Medicine
        • Nucleic acids research
        • 1987
        • 4,422
        • PDF